Clinical Trials Logo

Clinical Trial Summary

The CranioFix®2 PMCF study has been set up as an action within the framework of a proactive post-market surveillance system of the manufacturer. The aim of this observational study is to collect systematically and proactively data regarding the performance of CranioFix®2, like adverse events (AEs), handling and cosmetic outcome, under daily clinical practice when used as intended by the manufacturer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05119595
Study type Observational
Source Aesculap AG
Contact
Status Completed
Phase
Start date March 22, 2022
Completion date October 27, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Not yet recruiting NCT02418169 - Association Between Craniofacial Fractures and Brain Injuries: Diagnostic and Therapeutic Considerations N/A
Recruiting NCT06027411 - Assess the Clinical Effectiveness in AI Prioritising CT Heads
Recruiting NCT05427838 - Simulation Training in Emergency Department Imaging 2
Completed NCT04355442 - Evolution of Facial Trauma During COVID Containment Measures